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Soluble guanylyl cyclase (sGC) is a well-known target for
the treatment of cardiovascular diseases. Finding activa-
tors of this enzyme is an important goal in pharmaceutical
research labs.
The predominantly used method to determine the activity
of soluble sGC biochemically is based on a radioactive
assay format. This procedure is time-consuming, not fea-
sible for uHTS and does not allow for online-monitoring
of the reaction.
In order to be able to screen compound libraries and to
investigate the kinetic behaviour of sGC activators a lumi-
nescence based assay for sGC was developed.
The assay is sensitive, robust and stable for over-night runs
in screening. Reproducibility was checked in 384- and
1536-well plates. The assay allows for online-monitoring
of the sGC reaction.
The potency of different kinds of activators like NO-
donors, heme-dependend stimulators and heme-inde-
pendend activators was determined. The influence of
ODQ as a selective oxidizing reagent and SIN-1 as an NO-
donor on the activation by stimulators and activators was
checked. These two reagents were used to optimize the
sensitivity of the assay in order to find new lead structures.
Results from the uHTS will be presented and compared to
data generated with cell-based assays.
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